Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (231-240 of 316) with videos related to

Pageof 32
Sort By:
American Journal of Clinical Oncology|February 24, 2017
ACR Appropriateness Criteria® Resectable Pancreatic CancerWilliam E Jones, W Waren Suh, May Abdel-Wahab, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal CancerSuzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Cancer Medicine|February 10, 2022
High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapyColin Hill, Shuchi Sehgal, Wei Fu, et al.
Human Pathology|October 6, 2009
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patientsK Ranh Voong, Jon Davison, Timothy M Pawlik, et al.
International Journal of Surgical Oncology|August 31, 2012
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsSalma K Jabbour, Shyamal Patel, Joseph M Herman, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignanciesZhiyong Yang, Yu Chang, Kristy K Brock, et al.
Radiation Oncology (London, England)|September 29, 2011
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyAmol K Narang, Robert C Miller, Charles C Hsu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2012
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planningHaoming Qiu, Aaron T Wild, Hao Wang, et al.
Pageof 32

Showing results (231-240 of 316) with videos related to

Sort By:
Pageof 32
American Journal of Clinical Oncology|February 24, 2017
ACR Appropriateness Criteria® Resectable Pancreatic CancerWilliam E Jones, W Waren Suh, May Abdel-Wahab, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal CancerSuzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Cancer Medicine|February 10, 2022
High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapyColin Hill, Shuchi Sehgal, Wei Fu, et al.
Human Pathology|October 6, 2009
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patientsK Ranh Voong, Jon Davison, Timothy M Pawlik, et al.
International Journal of Surgical Oncology|August 31, 2012
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsSalma K Jabbour, Shyamal Patel, Joseph M Herman, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignanciesZhiyong Yang, Yu Chang, Kristy K Brock, et al.
Radiation Oncology (London, England)|September 29, 2011
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyAmol K Narang, Robert C Miller, Charles C Hsu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2012
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planningHaoming Qiu, Aaron T Wild, Hao Wang, et al.
Pageof 32